> top > docs > PMC:7205724 > spans > 414-634 > annotations

PMC:7205724 / 414-634 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
7 0-8 Disease denotes COVID-19 MESH:C000657245
10 13-16 Gene denotes IL6 Gene:3569
11 85-93 Disease denotes COVID-19 MESH:C000657245
17 119-122 Gene denotes IL6 Gene:3569
18 178-181 Gene denotes IL6 Gene:3569
19 146-154 Species denotes patients Tax:9606
20 98-109 Chemical denotes Tocilizumab MESH:C502936
21 160-168 Disease denotes COVID-19 MESH:C000657245
53 197-214 Species denotes novel coronavirus Tax:2697049

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T3 0-8 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 85-93 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 160-168 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 216-220 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T2 56-66 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes viral load http://purl.bioontology.org/ontology/MEDDRA/10062178

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T3 0-8 Species denotes COVID-19 NCBItxid:2697049
T4 85-93 Species denotes COVID-19 NCBItxid:2697049
T5 160-168 Species denotes COVID-19 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T8 10-94 Sentence denotes • IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.
T9 95-182 Sentence denotes • Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.
T10 184-192 Sentence denotes Abstract

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
7 0-8 Disease denotes COVID-19 MESH:C000657245
10 13-16 Gene denotes IL6 Gene:3569
11 85-93 Disease denotes COVID-19 MESH:C000657245
20 98-109 Chemical denotes Tocilizumab MESH:C502936
17 119-122 Gene denotes IL6 Gene:3569
19 146-154 Species denotes patients Tax:9606
21 160-168 Disease denotes COVID-19 MESH:C000657245
18 178-181 Gene denotes IL6 Gene:3569
53 197-214 Species denotes novel coronavirus Tax:2697049

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T1 13-16 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0
T45 119-122 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0
T89 178-181 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T59 0-8 NN denotes COVID-19
T60 10-11 LS denotes •
T61 13-16 NN denotes IL6
T62 17-27 VBZ denotes correlates
T63 28-32 IN denotes with
T64 33-41 NN denotes severity
T65 41-42 -COMMA- denotes ,
T66 43-54 NN denotes criticality
T67 54-55 -COMMA- denotes ,
T68 56-61 JJ denotes viral
T69 62-66 NN denotes load
T70 66-67 -COMMA- denotes ,
T71 68-71 CC denotes and
T72 72-81 NN denotes prognosis
T73 82-84 IN denotes of
T74 85-93 NN denotes COVID-19
T75 95-96 IN denotes •
T76 98-109 NNP denotes Tocilizumab
T77 109-110 -COMMA- denotes ,
T78 111-113 DT denotes an
T79 114-122 NN denotes anti-IL6
T80 122-123 -COMMA- denotes ,
T81 124-127 MD denotes can
T82 128-134 VB denotes confer
T83 135-142 NN denotes benefit
T84 143-145 IN denotes in
T85 146-154 NNS denotes patients
T86 155-159 IN denotes with
T87 160-168 NN denotes COVID-19
T88 169-172 CC denotes and
T89 173-177 JJ denotes high
T90 178-181 NN denotes IL6
T91 184-192 NN denotes Abstract
T92 193-196 DT denotes The
T93 197-202 JJ denotes novel
T94 203-214 NN denotes coronavirus
T95 214-215 -COMMA- denotes ,
R55 T62 T60 arg1Of correlates,•
R56 T61 T62 arg1Of IL6,correlates
R57 T62 T63 arg1Of correlates,with
R58 T71 T63 arg2Of and,with
R59 T64 T65 arg1Of severity,","
R60 T66 T65 arg2Of criticality,","
R61 T65 T67 arg1Of ",",","
R62 T69 T67 arg2Of load,","
R63 T69 T68 arg1Of load,viral
R64 T71 T70 arg1Of and,","
R65 T67 T71 arg1Of ",",and
R66 T72 T71 arg2Of prognosis,and
R67 T72 T73 arg1Of prognosis,of
R68 T74 T73 arg2Of COVID-19,of
R69 T82 T75 arg1Of confer,•
R70 T76 T77 arg1Of Tocilizumab,","
R71 T79 T77 arg2Of anti-IL6,","
R72 T79 T78 arg1Of anti-IL6,an
R73 T82 T80 arg1Of confer,","
R74 T76 T81 arg1Of Tocilizumab,can
R75 T82 T81 arg2Of confer,can
R76 T76 T82 arg1Of Tocilizumab,confer
R77 T83 T82 arg2Of benefit,confer
R78 T82 T84 arg1Of confer,in
R79 T85 T84 arg2Of patients,in
R80 T85 T86 arg1Of patients,with
R81 T88 T86 arg2Of and,with
R82 T87 T88 arg1Of COVID-19,and
R83 T90 T88 arg2Of IL6,and
R84 T90 T89 arg1Of IL6,high
R85 T94 T92 arg1Of coronavirus,The
R86 T94 T93 arg1Of coronavirus,novel
R87 T94 T95 arg1Of coronavirus,","

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T3 0-8 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 85-93 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 160-168 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T8 10-94 Sentence denotes • IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19.
T9 95-182 Sentence denotes • Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.
T10 184-192 Sentence denotes Abstract